… The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
… clinical criteria of antiphospholipid syndrome (APS), (b) to identify potential risk factors for …

… developed complications associated with antiphospholipid antibodies at … antiphospholipid
antibodies, especially associated with pregnancy, underscores the need to evaluate long-term …

… antiphospholipid antibodies (aPL) negativisation in patients with antiphospholipid syndrome
… When analysing the cardiovascular risk factors at diagnosis of the cohort, the patients had a …

… A high prevalence of other CV risk factors was observed in our population, but they did not
… Inherited thrombophilia was represented in one-fourth of patients, underlining the risk of …

… Antiphospholipid syndrome (APS) is a systemic autoimmune disease … complications (miscarriages,
fetal deaths and/or premature births) in the presence of antiphospholipid antibodies (…

… Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia associated with
the presence of persistent antiphospholipid antibodies … stratified in terms of the risk of future …

… Patients with antiphospholipid antibody syndrome (APS) have a high risk for rethrombosis. …
risks and benefits of each anticoagulation regimen were assessed at 2 different time points: at …

… term is a misnomer because it leads one to believe that people with lupus anticoagulants
are at risk for bleeding when, in fact, they are at risk … 1, the term ‘antiphospholipid syndrome’ (…

… antibodies with … complications is well established. The combination of aPL with either venous
or arterial thrombosis or obstetric complications is referred to as antiphospholipid syndrome …

… (APS) refers to the association between antiphospholipid antibodies and thrombosis risk or
… The association between antiphospholipid antibodies and the risk of premature birth due to …